Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGL-TX-PTDM: SGLT2i Effect on PTDM Development and Kidney Allograft Function in Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

NCT07682350 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07682350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07682350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGL-TX-PTDM: SGLT2i Effect on PTDM Development and Kidney Allograft Function in Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
October 1, 2029
Enrollment
184 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant recipient, non-diabetic patients, placebo control design, post transplant diabetes mellitus, randomized controlled trial (rct), sodium glucose co-transporter 2 inhibitors